242 related articles for article (PubMed ID: 32940605)
1. Antibody escape by polyomavirus capsid mutation facilitates neurovirulence.
Lauver MD; Goetschius DJ; Netherby-Winslow CS; Ayers KN; Jin G; Haas DG; Frost EL; Cho SH; Bator CM; Bywaters SM; Christensen ND; Hafenstein SL; Lukacher AE
Elife; 2020 Sep; 9():. PubMed ID: 32940605
[TBL] [Abstract][Full Text] [Related]
2. JCPyV VP1 Mutations in Progressive MultifocalLeukoencephalopathy: Altering Tropismor Mediating Immune Evasion?
Lauver MD; Lukacher AE
Viruses; 2020 Oct; 12(10):. PubMed ID: 33053912
[TBL] [Abstract][Full Text] [Related]
3. T cell deficiency precipitates antibody evasion and emergence of neurovirulent polyomavirus.
Lauver MD; Jin G; Ayers KN; Carey SN; Specht CS; Abendroth CS; Lukacher AE
Elife; 2022 Nov; 11():. PubMed ID: 36341713
[TBL] [Abstract][Full Text] [Related]
4. CD8 T Cells and STAT1 Signaling Are Essential Codeterminants in Protection from Polyomavirus Encephalopathy.
Mockus TE; Netherby-Winslow CS; Atkins HM; Lauver MD; Jin G; Ren HM; Lukacher AE
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996425
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
6. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy.
Diotti RA; Mancini N; Clementi N; Sautto G; Moreno GJ; Criscuolo E; Cappelletti F; Man P; Forest E; Remy L; Giannecchini S; Clementi M; Burioni R
Antiviral Res; 2014 Aug; 108():94-103. PubMed ID: 24909571
[TBL] [Abstract][Full Text] [Related]
8. Understanding polyomavirus CNS disease - a perspective from mouse models.
Ayers KN; Carey SN; Lukacher AE
FEBS J; 2022 Oct; 289(19):5744-5761. PubMed ID: 34145975
[TBL] [Abstract][Full Text] [Related]
9. Polyomavirus Wakes Up and Chooses Neurovirulence.
Butic AB; Spencer SA; Shaheen SK; Lukacher AE
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896889
[TBL] [Abstract][Full Text] [Related]
10. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy.
Zheng HY; Takasaka T; Noda K; Kanazawa A; Mori H; Kabuki T; Joh K; Oh-Ishi T; Ikegaya H; Nagashima K; Hall WW; Kitamura T; Yogo Y
J Gen Virol; 2005 Jul; 86(Pt 7):2035-2045. PubMed ID: 15958683
[TBL] [Abstract][Full Text] [Related]
11. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
12. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
13. Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.
Qin Q; Shwetank ; Frost EL; Maru S; Lukacher AE
J Virol; 2016 May; 90(10):5187-99. PubMed ID: 26984726
[TBL] [Abstract][Full Text] [Related]
14. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
[TBL] [Abstract][Full Text] [Related]
15. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
16. Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Nelson CD; Ströh LJ; Gee GV; O'Hara BA; Stehle T; Atwood WJ
J Virol; 2015 Apr; 89(7):3910-21. PubMed ID: 25609820
[TBL] [Abstract][Full Text] [Related]
17. BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients.
Rossi F; Li X; Jacobson L; Levine AJ; Chen Y; Palella FJ; Margolick J; Viscidi R
Virology; 2015 Nov; 485():467-72. PubMed ID: 26356797
[TBL] [Abstract][Full Text] [Related]
18. CD4 T cells control development and maintenance of brain-resident CD8 T cells during polyomavirus infection.
Mockus TE; Shwetank ; Lauver MD; Ren HM; Netherby CS; Salameh T; Kawasawa YI; Yue F; Broach JR; Lukacher AE
PLoS Pathog; 2018 Oct; 14(10):e1007365. PubMed ID: 30372487
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the VP1 loop mutations widespread among JC polyomavirus isolates associated with progressive multifocal leukoencephalopathy.
Zheng HY; Ikegaya H; Takasaka T; Matsushima-Ohno T; Sakurai M; Kanazawa I; Kishida S; Nagashima K; Kitamura T; Yogo Y
Biochem Biophys Res Commun; 2005 Aug; 333(3):996-1002. PubMed ID: 15964545
[TBL] [Abstract][Full Text] [Related]
20. Serum IgG antibodies from healthy subjects up to 100 years old react to JC polyomavirus.
Bononi I; Mazzoni E; Pietrobon S; Manfrini M; Torreggiani E; Rossini M; Lotito F; Guerra G; Rizzo P; Martini F; Tognon M
J Cell Physiol; 2018 Aug; 233(8):5513-5522. PubMed ID: 29323725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
